Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|
Titan Pharmaceuticals, Inc. last posted its earnings results on Friday, March 31st, 2023. The company reported $-2.20165 earnings per share for the quarter, topping analysts' consensus estimates of $-4.4 by $2.19835. The company had revenue of 0 for the quarter and had revenue of 184,000 for the year. Titan Pharmaceuticals, Inc. has generated $-7 earnings per share over the last year ($-7.41 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Titan Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
01/03/2025 | Q3 2024 | -$0.83 | $0 | $0 | ||
08/15/2024 | Q2 2024 | -$2.29 | $0 | $0 | ||
05/15/2024 | Q1 2024 | -$1.24 | $0 | |||
04/01/2024 | Q4 2023 | -$2.52 | $81,000 | |||
11/14/2023 | Q3 2023 | -$0.45 | $4,000 | |||
08/14/2023 | Q2 2023 | -$2.11 | $1,000 | |||
05/15/2023 | Q1 2023 | -$2.20 | $98,000 | |||
03/31/2023 | Q4 2022 | -$4.40 | $0.00 | $51,000 | ||
11/14/2022 | Q3 2022 | -$4.20 | -$3.61 | 0.59 | $4,000 | |
08/11/2022 | Q2 2022 | -$5.20 | -$0.18 | 5.02 | $150,000 | |
05/16/2022 | Q1 2022 | -$0.24 | $192,000 | |||
03/25/2022 | Q4 2021 | -$7.00 | -$0.26 | 6.74 | $135,000 | |
11/15/2021 | Q3 2021 | -$0.35 | -$0.19 | 0.16 | $1.09 M | $264,000 |
08/16/2021 | Q2 2021 | -$0.35 | -$0.17 | 0.18 | $1.00 M | $445,000 |
05/17/2021 | Q1 2021 | -$0.85 | -$0.28 | 0.57 | $682,000 | |
03/31/2021 | Q4 2020 | -$1.33 | -$0.33 | 1 | $1.06 M | |
11/16/2020 | Q3 2020 | -$24.02 | -$1.51 | 22.51 | $1.00 M | $1.12 M |
08/14/2020 | Q2 2020 | -$18.02 | -$1.47 | 16.55 | $823,000 | $1.33 M |
05/15/2020 | Q1 2020 | -$2.03 | $1.34 M | |||
03/30/2020 | Q4 2019 | -$0.08 | -$1.43 | -1.35 | $1.22 M |
Titan Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
In the previous quarter, Titan Pharmaceuticals, Inc. (:TTNP) reported $-2.20165 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.4 by $2.19835.
The conference call for Titan Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Titan Pharmaceuticals, Inc.'s latest earnings report can be read online.
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded annual revenue of $184,000.
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded net income of $184,000. Titan Pharmaceuticals, Inc. has generated $-7.41 earnings per share over the last four quarters.
Titan Pharmaceuticals, Inc. (:TTNP) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is 0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED